Marshall B. Elam

机构：University of Tennessee Health Science Center, Ducks Unlimited, University of West Florida · ORCID：0000-0002-1063-1557

发表论文 119 篇 · 总被引 10431 次 · h-index 44

代表论文

• Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (2022 · New England Journal of Medicine · 被引 747)
• Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study (2018 · American Heart Journal · 被引 323)
• Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes (2016 · JAMA Cardiology · 被引 194)
• Optimizing Cholesterol Treatment in Patients With Muscle Complaints (2017 · Journal of the American College of Cardiology · 被引 193)
• Lipid-Modifying Therapies and Risk of Pancreatitis (2012 · JAMA · 被引 190)
• FoxO1 Inhibits Sterol Regulatory Element-binding Protein-1c (SREBP-1c) Gene Expression via Transcription Factors Sp1 and SREBP-1c (2012 · Journal of Biological Chemistry · 被引 148)